Schott Phar­ma plans Frank­furt Stock Ex­change list­ing by end of year to boost of­fer­ing to in­jectable drug com­pa­nies

Drug con­tain­er sup­pli­er Schott Phar­ma re­vealed Wednes­day it is mak­ing plans to be pub­licly list­ed on the Frank­furt Stock Ex­change by the end of the year in a bid to fund the com­pa­ny’s fur­ther ex­pan­sion in­to the in­jectable drug mar­ket.

The cap­i­tal raised will in­crease the Mainz, Ger­many-head­quar­tered com­pa­ny’s pro­duc­tion ca­pac­i­ty at its Ger­man and US fa­cil­i­ties and fund a new man­u­fac­tur­ing site in Hun­gary. The IPO will al­so sup­port the com­pa­ny’s goal to be­come cli­mate-neu­tral by 2030.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER